Lv5
936 积分 2023-09-20 加入
Optimizing CAR-T Therapy in Diffuse Large B-Cell Lymphoma: Biological Determinants and Translational Strategies Across the Therapeutic Continuum
1小时前
已完结
Preclinical discovery and clinical development of glofitamab in relapsed/ refractory large B-cell lymphomas
5天前
已完结
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
6天前
已完结
CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations
6天前
已完结
p53: 800 million years of evolution and 40 years of discovery
8天前
已完结
FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function
14天前
已完结
CAR T cell persistence in cancer
14天前
已完结
Memory programming and new manufacturing paradigms in CAR-T cell therapy
14天前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
14天前
已完结
Current state of CAR-T cell therapies for solid tumors
14天前
已完结
皖公网安备34019202002308
